Post-Marketing Surveillance Study of the Live Attenuated Varicella Vaccine (SKYVaricella Inj.) in Korean Children
Infection & Chemotherapy · 2026 · 58 (1) · 49
DOI: 10.3947/ic.2025.0095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection & Chemotherapy, 2026. Verfasst von Hyunjeong Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affair, SK bioscience Co., Ltd., Incheon, Korea. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: SK bioscience.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Affair, SK bioscience Co., Ltd., Incheon, Korea.
- Medical Affair, SK bioscience Co., Ltd., Incheon, Korea. hykim620@sk.com.
ORCID-Profile: Hyunjeong Kim, Kihyun Kim, Hye Young Kim
Förderung
- SK bioscience
Zitieren
APA
Kim, H., Kim, K., & Kim, H. Y. (2026). Post-Marketing Surveillance Study of the Live Attenuated Varicella Vaccine (SKYVaricella Inj.) in Korean Children. Infection & Chemotherapy, 58(1), 49. https://doi.org/10.3947/ic.2025.0095
Vancouver
Kim H, Kim K, Kim HY. Post-Marketing Surveillance Study of the Live Attenuated Varicella Vaccine (SKYVaricella Inj.) in Korean Children. Infection & Chemotherapy. 2026;58(1):49. doi:10.3947/ic.2025.0095
BibTeX
@article{Kim2026,
author = {Kim, Hyunjeong and Kim, Kihyun and Kim, Hye Young},
title = {Post-Marketing Surveillance Study of the Live Attenuated Varicella Vaccine (SKYVaricella Inj.) in Korean Children},
journal = {Infection & Chemotherapy},
year = {2026},
volume = {58},
number = {1},
pages = {49},
doi = {10.3947/ic.2025.0095}
}
EUVIMED